Lactulose 667 milligram/milliliter Oral Solution Clinical Trials

1 actively recruiting trial

Also known as: Lactulose syrup

Filter by location:

Other1 trial

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.